Advanced search
Publication Cover
Pharmaceutical Development and Technology Volume 18, 2013 - Issue 4
Submit an article Journal homepage
462
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Multivesicular liposomes for sustained release of naltrexone hydrochloride: design, characterization and in vitro/in vivo evaluation

Lijun SunPharmaceutical Department, 309 Hospital of L.A.P. Beijing, China
,
Tao WangPharmaceutical Department, Beijing Institute of Pharmacology and Toxicology, Beijing, China
,
Lijun GaoPharmaceutical Department, Beijing Institute of Pharmacology and Toxicology, Beijing, China
,
Dongqin QuanPharmaceutical Department, Beijing Institute of Pharmacology and Toxicology, Beijing, China
&
Duanhao FengPharmaceutical Department, 309 Hospital of L.A.P. Beijing, ChinaCorrespondence[email protected]
Pages 828-833 | Received 15 Feb 2012, Accepted 27 May 2012, Published online: 03 Jul 2012

References

  • Tucker TK, Ritter AJ. Naltrexone in the treatment of heroin dependence: a literature review. Drug Alcohol Rev 2000;19:73–82.
  • Thomas CP, Wallack SS, Lee S, McCarty D, Swift R. Research to practice: adoption of naltrexone in alcoholism treatment. J Subst Abuse Treat 2003;24:1–11.
  • Rossi S. [Prognostic/predictive role of epidermal growth factor receptor (EGFR) in colorectal carcinoma]. Pathologica 2005;97:180–182.
  • Giannola LI, De Caro V, Giandalia G. Release of naltrexone on buccal mucosa: Permeationstudies, histological aspects and matrix system design. Eur J Pharm Biopharm 2007;67:425–433.
  • Yin W, Akala EO, Taylor RE. Design of naltrexone-loaded hydrolyzable crosslinked nanoparticles. Int J Pharm 2002;244:9–19.
  • Valiveti S, Paudel KS, Hammell DC, Hamad MO, Chen J, Crooks PA et al. In vitro/in vivo correlation of transdermal naltrexone prodrugs in hairless guinea pigs. Pharm Res 2005;22:981–989.
  • Valiveti S, Hammell DC, Paudel KS, Hamad MO. In vivo evaluation of 3-O-alkyl ester transdermal prodrugs of naltrexone in hairless guinea pigs. J Contr Release 2005;102:509–520.
  • Kim S, Turker MS, Chi EY, Sela S, Martin GM. Preparation of multivesicular liposomes. Biochim Biophys Acta 1983;728:339–348.
  • Ye Q, Asherman J, Stevenson M, Brownson E. DepoFoamTE technology: a vehicle for controlled delivery of protein and peptide drugs. J Contr Release 2000;64:155–166.
  • Dai C, Wang B, Zhao H, Li B, Wang J. Preparation and characterization of liposomes-in-alginate (LIA) for protein delivery system. Colloids and Surfaces B: Biointerfaces 2006;47:205–210.
  • Katre NV, Asherman J, Schaefer H, Hora M. Multivesicular liposome (DepoFoam) technology for the sustained delivery of insulin-like growth factor-I (IGF-I). J Pharm Sci 1998;87:1341–1346.
  • Howell SB. Clinical applications of a novel sustained-release injectable drug delivery system: DepoFoam technology. Cancer J 2001;7:219–227.
  • Ramprasad MP, Anatharamaian GM, Garber DW. Sustained-delivery of an apolipoprotain E-peptidomimetic using multivesicular liposomes lower serum cholesterol levels. J control Rel 2002;79:207–218.
  • Mysore SP, Zasadzinsk JA. Topology of Multivesicular liposomes: A model biliduid foam. Langmuir 1996;12:4704–4708.
  • Zhong HJ, Deng YJ. Multivesicular liposome formulation for the sustained delivery of breviscapine. Int J Pharm 2005;301:15–24.
  • Grayson LS, Hansbrough JF, Zapata-Sirvent RL, Kim T, Kim S. Pharmacokinetics of DepoFoam gentamicin delivery system and effect on soft tissue infection. J Surg Res 1993;55:559–564.
  • Ritger PL, Peppas NA. A simple equation for description of solute release I. Fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J Contr Release 1987;5:23–36.
  • Wang T, Gao L, Quan D. Multivesicular liposome (MVL) sustained delivery of a novel synthetic cationic GnRH antagonist for prostate cancer treatment. J Pharm Pharmacol 2011;63:904–910.
  • Eskola JU, Nevalainen TJ, Kortesuo P. Immunoreactive pancreatic phospholipase A2 and catalytically active phospholipases A2 in serum from patients with acute pancreatitis. Clin Chem 1988;34:1052–1054.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.